The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 22, 2013
Filed:
May. 05, 2008
Zhaoning Zhu, Plainsboro, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Zhong-yue Sun, Parlin, NJ (US);
Gioconda Gallo, Summit, NJ (US);
Theodros Asberom, West Orange, NJ (US);
Xianhai Huang, Warren, NJ (US);
Xiaohong Zhu, Edison, NJ (US);
Mark D. Mcbriar, Clinton, NJ (US);
Dmitri A. Pissarnitski, Scotch Plains, NJ (US);
Zhiqiang Zhao, Scotch Plains, NJ (US);
Ruo Xu, Watchung, NJ (US);
Hongmei LI, Warren, NJ (US);
Anandan Palani, Bridgewater, NJ (US);
Johannes H. Voigt, Cranford, NJ (US);
Robert D. Mazzola, Jr., Stewartsville, NJ (US);
John Clader, Cranford, NJ (US);
Hubert Josien, Jersey City, NJ (US);
Jun Qin, Edison, NJ (US);
Zhaoning Zhu, Plainsboro, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Zhong-Yue Sun, Parlin, NJ (US);
Gioconda Gallo, Summit, NJ (US);
Theodros Asberom, West Orange, NJ (US);
Xianhai Huang, Warren, NJ (US);
Xiaohong Zhu, Edison, NJ (US);
Mark D. McBriar, Clinton, NJ (US);
Dmitri A. Pissarnitski, Scotch Plains, NJ (US);
Zhiqiang Zhao, Scotch Plains, NJ (US);
Ruo Xu, Watchung, NJ (US);
Hongmei Li, Warren, NJ (US);
Anandan Palani, Bridgewater, NJ (US);
Johannes H. Voigt, Cranford, NJ (US);
Robert D. Mazzola, Jr., Stewartsville, NJ (US);
John Clader, Cranford, NJ (US);
Hubert Josien, Jersey City, NJ (US);
Jun Qin, Edison, NJ (US);
Other;
Abstract
The present invention provides a novel class of heterocyclic compounds of Formula (I) as modulators of gamma secretase, wherein the definitions of the variables of Formula (I) are defined herein, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the central nervous system using such compounds or pharmaceutical compositions.